Medical Oncology 3 – Head and Neck Cancers

The centre’s services are divided into outpatient services and inpatient services.

Outpatient services are available every day from 8.30 am to 4.00 pm; during these hours, we see patients currently undergoing treatment, as well as those who have completed their treatment and are attending for follow-up appointments.

In addition, there are 6 slots available each week for ‘Initial Oncology Consultations’. These services are provided under the National Health Service (NHS) and can be booked by telephone on (+39) 02 2390 2150 (Mon–Fri 9.00–10.00) or by email at amo@istitutotumori.mi.it

For all types of booking (including telephone bookings), you must have your  health card, a medical prescription stating the clinical referral, and your tax code.

Once the appointment has been scheduled, patients are asked to go to the CUP (Central Appointment Service) upon arrival at the Institute to register. The administrative staff will provide directions to the consultation room.

In line with the multidisciplinary approach required by this condition, two initial consultation clinics are held in collaboration with colleagues from Radiotherapy, Maxillofacial Surgery and Otorhinolaryngology, on Tuesdays and Thursdays respectively from 2.00 pm to 4.00 pm. These services are also provided under the National Health Service (NHS) and can be booked by telephone on (+39) 02 2390 1. The outpatient consultation is the first point of contact with the facility.

The inpatient ward is located on the 3rd floor of Block F and has 7 beds. The ward consists of twin rooms with en-suite bathrooms. Inpatient care is reserved for patients requiring specific medical treatments and/or supportive care during integrated chemoradiotherapy and throughout all stages of the disease. 

Medical treatment of  

• locally advanced head and neck cancers  
• recurrent/metastatic head and neck cancers
• advanced non-melanoma skin cancers (squamous cell carcinoma, basal cell carcinoma, carcinomas of the skin appendages)
• Advanced malignant thyroid tumours